Search research articles
Contact Us
Filters
Showing results (61-70 of 79) with videos related to
Page
of 8
Sort By:
Bone Marrow Transplantation
|
July 23, 2020
Geriatric syndromes in 2-year, progression-free survivors among older recipients of allogeneic hematopoietic cell transplantation
Richard J Lin, Raymond E Baser, Theresa A Elko, et al.
Blood Advances
|
December 8, 2020
High progression-free survival after intermediate intensity double unit cord blood transplantation in adults
Juliet N Barker, Sean M Devlin, Kristine A Naputo, et al.
JAMA Network Open
|
May 5, 2026
Hematopoietic Cell Transplant Access and Patient Diversity
Rachel Cusatis, Jianqun Kou, Caitrin Bupp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2025
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Monzr M Al Malki, Stephanie Bo-Subait, Brent Logan, et al.
Transplantation and Cellular Therapy
|
December 30, 2022
Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial
Bronwen E Shaw, Antonio Martin Jimenez-Jimenez, Linda J Burns, et al.
Journal of Palliative Medicine
|
March 29, 2020
Characteristics and Impact of Post-Transplant Interdisciplinary Palliative Care Consultation in Older Allogeneic Hematopoietic Cell Transplant Recipients
Richard J Lin, Abigail G Cohen, Stacy M Stabler, et al.
Leukemia & Lymphoma
|
September 3, 2021
Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant
Jan Philipp Bewersdorf, Andriy Derkach, Lohith Gowda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 27, 2021
National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide
Bronwen E Shaw, Antonio Martin Jimenez-Jimenez, Linda J Burns, et al.
Blood Advances
|
June 12, 2025
Bone marrow and blood demonstrate distinct immune reconstitution patterns and correlations with relapse post-transplant
Susan DeWolf, Jason Kuttiyara, Paola Vinci, et al.
Transplantation and Cellular Therapy
|
March 17, 2021
Cellular Therapy During COVID-19: Lessons Learned and Preparing for Subsequent Waves
Mariam T Nawas, Gunjan L Shah, Darren R Feldman, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 79) with videos related to
Sort By:
Page
of 8
Bone Marrow Transplantation
|
July 23, 2020
Geriatric syndromes in 2-year, progression-free survivors among older recipients of allogeneic hematopoietic cell transplantation
Richard J Lin, Raymond E Baser, Theresa A Elko, et al.
Blood Advances
|
December 8, 2020
High progression-free survival after intermediate intensity double unit cord blood transplantation in adults
Juliet N Barker, Sean M Devlin, Kristine A Naputo, et al.
JAMA Network Open
|
May 5, 2026
Hematopoietic Cell Transplant Access and Patient Diversity
Rachel Cusatis, Jianqun Kou, Caitrin Bupp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2025
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Monzr M Al Malki, Stephanie Bo-Subait, Brent Logan, et al.
Transplantation and Cellular Therapy
|
December 30, 2022
Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial
Bronwen E Shaw, Antonio Martin Jimenez-Jimenez, Linda J Burns, et al.
Journal of Palliative Medicine
|
March 29, 2020
Characteristics and Impact of Post-Transplant Interdisciplinary Palliative Care Consultation in Older Allogeneic Hematopoietic Cell Transplant Recipients
Richard J Lin, Abigail G Cohen, Stacy M Stabler, et al.
Leukemia & Lymphoma
|
September 3, 2021
Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant
Jan Philipp Bewersdorf, Andriy Derkach, Lohith Gowda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 27, 2021
National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide
Bronwen E Shaw, Antonio Martin Jimenez-Jimenez, Linda J Burns, et al.
Blood Advances
|
June 12, 2025
Bone marrow and blood demonstrate distinct immune reconstitution patterns and correlations with relapse post-transplant
Susan DeWolf, Jason Kuttiyara, Paola Vinci, et al.
Transplantation and Cellular Therapy
|
March 17, 2021
Cellular Therapy During COVID-19: Lessons Learned and Preparing for Subsequent Waves
Mariam T Nawas, Gunjan L Shah, Darren R Feldman, et al.
Page
of 8